Fortitude Family Office’s Mangoceuticals MGRX Stock Holding History

Fortitude Family Office’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510	Hold	1,343	–	–	﹤0.01%	1973
2026 Q1	$484	Buy	1,343 +965	+255%	+$462	﹤0.01%	1741
2025 Q4	$280	Buy	+378	New	+$613	﹤0.01%	1835

Other funds holding MGRX

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Fortitude Family Office's MGRX Position: Q2 2026 in Review

Fortitude Family Office held its Mangoceuticals (MGRX) position steady in Q2 2026 at 1,343 shares worth $510. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Fortitude Family Office first reported a position in MGRX in Q4 2025 and has held it in 3 quarters since. 2 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

Fortitude Family Office held 1,343 shares of Mangoceuticals worth $510 as of Q2 2026.
Fortitude Family Office left its Mangoceuticals share count unchanged in Q2 2026.
Mangoceuticals made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1973 holding.
Fortitude Family Office first reported a position in Mangoceuticals in Q4 2025 and has held it in 3 quarters since.
2 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.